Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
August 20, 2001
- We Don't Want Reform That Profits Only Generic Makers: EMA President
August 20, 2001
- Sankyo, UAB Discover New Antibody with Tumoricidal Activity
August 20, 2001
- Reimbursement Prices to Be Set for 142 Medical Material Categories
August 20, 2001
- ACCJ White Paper Calls For Deregulations in Healthcare Services
August 20, 2001
- Bronchodilators Recommended for COPD: NBI Seminar
August 20, 2001
- Subcommittee Discusses Prices of Medical Materials
August 20, 2001
- Novo Nordisk: InnoLet, New Insulin Kit Targeted at the Elderly
August 20, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 20, 2001
- Fresenius to Supply Artificial Kidneys to Teijin
August 20, 2001
- Compounds under R&D by Japanese Makers in US Show Rapid Increases: JETRO Survey
August 20, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 20, 2001
- Canopus Develops New Image Distribution System for Hospitals
August 20, 2001
- BUSINESS NEWS IN BRIEF -1-
August 20, 2001
- MEDICAL DEVICE NEWS IN BRIEF
August 20, 2001
- BUSINESS NEWS IN BRIEF -2-
August 20, 2001
- Takara Launches 2 Additional DNA Chips
August 20, 2001
- Savings of \1.4 Trillion Possible by Reducing Drug Cost to 16%: Council Report
August 20, 2001
- Study on Diagnostic Method Using PALSAR Selected by JHSF
August 20, 2001
- 6th Designation for Quality Reevaluation Approved
August 20, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…